Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LOPERAMIDA OPKO 2 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LOPERAMIDA OPKO 2 MG CAPSULAS DURAS EFG

Approved

STANDARD

LOPERAMIDA OPKO 2 MG CAPSULAS DURAS EFG

Opko Health Spain S.L.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 4, 2023
Approval ID: 421ee0d43ec8db42
Company: Opko Health Spain S.L.U.
Type: Standard

Approval Details

Approval Id: 421ee0d43ec8db42
Drug Cima Aemps Name: LOPERAMIDA OPKO 2 MG CAPSULAS DURAS EFG
Register Number: 88777
Holder Company Name: Opko Health Spain S.L.U.
Marketing Company Name: Opko Health Spain S.L.U.
Authorization Date: 2023-10-04
Dosage Form: CÁPSULA DURA
Dose: 2 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: No
Company Name: Opko Health Spain S.L.U.

Active Ingredients

LOPERAMIDA HIDROCLORURO

2 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 4, 2023

Approval ID

421ee0d43ec8db42

Type

Standard

Back to CIMA-AEMPS Approvals